Related by context. All words. (Click for frequent words.) 67 novel anti infective 67 potent anticancer 67 IMiDs ® 66 metaglidasen 66 IMiDs R 66 adrenergic regulation 66 novel therapeutic antibodies 66 NuMimetic TM 65 oral prodrug 65 novel peptide 65 Ostabolin C TM 65 protein kinase inhibitors 65 PI3K/Akt pathway inhibitor 65 oral ghrelin agonist 65 HepDirect R 65 Miraxion Amarin lead 64 DNA RNA Medicines 64 novel immunomodulatory 64 neuronal nicotinic receptor NNR 64 potent suppressor 64 therapeutic monoclonal antibody 64 Curaxin CBLC# 64 inhibit metastasis 64 favorable pharmacokinetic 64 highly selective endothelin 64 mertansine 64 MTP inhibitor 64 acadesine 64 biased ligand 63 histone deacetylase HDAC inhibitors 63 targeted radiotherapeutic 63 Aganocide ® 63 nitric oxide donating 63 INS# [001] 63 kidney urologic 63 CYT# potent vascular disrupting 63 novel antifolate 63 selective estrogen receptor modulator 63 rxRNA 63 PORxin TM 63 accumulate preferentially 63 immunomodulating 63 ALTROPANE R 63 novel anticancer 63 gastro intestinal inflammation 63 multitargeted 63 JAK inhibitors 63 antimitotic 63 skeletal sarcomere activators 63 Nanobody 63 GVAX ® 63 Squalamine 63 Panzem R 63 OMP #M# 63 AKT inhibitor 63 intranasal insulin product 62 HDL Mimetic Peptide 62 sulfonylhydrazine class 62 oncolytic virus therapies 62 OMP #R# 62 IAP inhibitors 62 immune modulating 62 investigational protease inhibitor 62 CB2 selective 62 mda 7 62 Nanobody ® 62 anticoagulant reversing agent 62 midstage clinical 62 orally bioavailable 62 IL-#/# 62 platelet aggregation inhibitors 62 anti neoplastic 62 nucleoside tide 62 oral antiviral 62 R#/MEM # 62 alvespimycin 62 vinca alkaloid 62 delivery polymer matrix 62 SuperAntibody 62 oral immunomodulatory 62 IMPDH inhibitor 62 PDE4 inhibitor 62 isoform selective 62 antiproliferative 62 Angiocept 62 telomerase therapeutic 62 EP #R 62 proteasome inhibitor 62 Mipomersen 62 GPR# agonist 62 LymphoStat B TM 62 GRN# 62 Provectus Pharmaceuticals specializes 62 humanised monoclonal antibody 62 THR beta agonist 62 anticancer therapeutics 62 triggers apoptosis programmed 61 Pruvel TM 61 PDE# 61 orally administered inhibitor 61 AAG geldanamycin analog 61 candidate deforolimus 61 ENMD # 61 Anti angiogenic 61 humanized therapeutic 61 signal transduction inhibitor 61 cyclophilin inhibitors 61 hypoxia activated prodrug 61 novel immunotherapeutic 61 Curaxin 61 Marqibo TM 61 Selective Electrochemical Tumor Ablation 61 recombinant biopharmaceutical 61 gallium containing 61 vaccines oncolytic virus 61 pan genotypic 61 next generation URAT1 61 Archexin 61 treat nicotine addiction 61 cancer immunotherapies 61 RNA antagonists 61 Factor VIIa 61 dimebon latrepirdine 61 vascular disrupting agents 61 JAK2 inhibitor 61 PEGylated interferon 61 GRNOPC1 contains 61 epothilones 61 Pentad TM 61 tubulin binding 61 BLyS specific 61 CCR9 antagonist 61 cosmetic cosmeceutical products 61 YONDELIS 61 MKC# MT 61 PKC# 61 histone deacetylase inhibitor 61 tubulin inhibitor 61 Adnectin 61 brain penetrant 61 Pyridorin 61 Tyrima 61 Zalypsis 61 Panzem R NCD 61 HQK 61 ATRA IV 61 potently inhibit 61 inhibit angiogenesis 61 erlotinib Tarceva ® 61 2 methoxyestradiol 61 Locked Nucleic Acid LNA 61 investigational humanized monoclonal antibody 61 topical PTH #-# 61 5 HT2A serotonin 61 Fc fusion protein 60 AVEO integrates proprietary 60 Panzem 60 antibacterial antiviral 60 Personalized Immunotherapy 60 non nucleoside HCV 60 preclinical compounds 60 therapeutic peptide 60 staphylococcal vaccine 60 ANAVEX #-# [002] 60 Homspera TM 60 Panzem NCD 60 CB2 receptor 60 OncoVex 60 enhance ApoA 60 incyclinide 60 Pimavanserin 60 using VIAdel TM 60 aurora kinase 60 anti amnesic 60 inhibit EGFR 60 chimeric monoclonal antibody 60 CK # novel 60 evaluating tivozanib 60 Camptothecin 60 CB2 receptor selective 60 novel DACH platinum 60 maximally tolerated lipid lowering 60 IAP inhibitor 60 Aganocide 60 AVEO Pharmaceuticals NASDAQ 60 Stapled Peptide 60 class mGluR5 inhibitor 60 CXB# 60 Combivir Kivexa 60 pan BCR ABL 60 SERMs 60 molecular imaging radiopharmaceutical 60 Nalmefene 60 HGS ETR1 mapatumumab 60 liposomal formulation 60 histone deacetylase HDAC 60 Smac mimetics 60 ONCONASE R 60 oxazolidinone 60 inhibit telomerase 60 HCV polymerase 60 HepeX B TM 60 romazarit 60 potent antiproliferative 60 non nucleoside inhibitor 60 non porcine pancreatic 60 immunotherapeutic vaccine 60 ABL inhibitor 60 NTDDS 60 defensin mimetic antibiotic 60 Myolimus 60 selective estrogen receptor modulators 60 selective androgen receptor modulator 60 polymer conjugate technology 60 Aplidin 60 epothilone 60 bortezomib Velcade 60 GMX# 60 synthetic cannabinoid compounds 60 Exelixis compounds 60 adenosine A2A 60 proprietary PEGylation 60 synthetic retinoid 60 telomerase activator 60 TransVax ™ 60 inflammatory autoimmune diseases 60 neuronal nicotinic receptors NNRs 60 topically delivered 60 Lixivaptan 60 candidates Azedra TM 60 anti secretory 60 DG# compounds targeting 60 antiviral antibacterial 60 Maxy G# 60 gamma secretase inhibitor 60 potent neuroprotective 60 CDK cyclin dependent 59 small molecule tyrosine 59 IMiDs ® compound 59 dasatinib Sprycel 59 DXL# 59 Pathway Inhibitor 59 antiangiogenesis therapies 59 Sangamo ZFP technology 59 A3 adenosine receptor 59 CORT # 59 immunotoxin 59 ADCC enhanced 59 optical biosensors 59 cortisol synthesis 59 tiapamil 59 DNA methyltransferase inhibitors 59 estrogen receptor modulator 59 Spiegelmer 59 eligen 59 proprietary biomaterials 59 antineoplastic 59 NEUGENE 59 NNRs 59 Kosan dependence 59 demonstrated antitumor activity 59 isatoribine 59 intranasal formulation 59 XL# anticancer compounds 59 TRIOLEX HE# APOPTONE HE# 59 activate SIRT1 59 novel histone deacetylase 59 MSCRAMM ® 59 Posiphen TM 59 calcitonin gene related 59 inhibit KSP 59 oral dihydropyrimidine dehydrogenase DPD 59 biotherapeutic drugs 59 antisense drug 59 neurokinin 1 59 Isis antisense 59 antitumoral 59 interferon alpha IFN 59 apoptosis inducers 59 Teriflunomide 59 Valproic acid 59 Pancreate 59 acyclovir Lauriad R 59 OXIGON TM 59 Ampakine compounds 59 anionic backbone 59 development peramivir neuraminidase 59 development diagnostics combinatorial 59 radezolid 59 TÎ ² 4 59 TKM PLK1 59 HSP# inhibitors 59 PSN# [001] 59 Tesetaxel 59 hapten 59 novel VDA molecule 59 sorafenib tablets 59 hepatoprotective agent 59 MCSP respectively 59 neuro inflammatory 59 retaspimycin 59 molecularly targeted 59 apricitabine ATC 59 HSP# inhibitor 59 potent cytotoxic 59 Kahalalide F 59 Annamycin 59 rhITF 59 JAK3 inhibitor 59 anti atherogenic 59 Selzentry Celsentri 59 R sorafenib tablets 59 Tarvacin Anti Cancer 59 molecular imaging radiopharmaceuticals 59 TLR7 agonist 59 Tß4 59 CD# CEA 59 neuro protective 59 protein receptors lectins 59 FOLFOX6 chemotherapy regimen 59 multi kinase inhibitor 59 selective kinase inhibitors 59 TRAIL receptor antibodies 59 rheumatoid arthritis thrombocytopenia 59 microtubule inhibitor 59 Solazed TM 59 cMET 59 orally inhaled migraine 59 mGluR2 NAM 59 Trastuzumab DM1 59 XL# XL# XL# XL# 59 proteasome inhibitors 59 antiangiogenic 59 Abiraterone acetate 59 antifibrotic 59 generation NEUGENE antisense 59 cardio metabolic diseases 59 hormone LHRH antagonist 59 IMA# 59 nasally delivered 59 ZFP Therapeutics 59 IL# PE#QQR 59 purinergic receptors P#X# 59 diagnostic molecular imaging 59 phosphatidylserine PS targeting 59 Darapladib 59 Sphingomab TM 59 progressive metastatic prostate 59 #ME# 59 selectively modulate 59 histone deacetylase 59 oral Janus kinase 59 Trofex 59 Homspera ® 59 novel L DOS# 59 small molecule Hedgehog 59 epigenetic therapies 59 Sapacitabine 59 fusion enhancers 59 Presents Preclinical Data 59 pan HDAC inhibitor 59 selective kinase inhibitor 59 Protexia ® 59 telomerase inhibitor drug 59 enzyme inhibitor 59 antisense inhibitors 59 imatinib Gleevec ® 59 Xcytrin R 59 Accelerated Intelligent 59 vaccine GRNVAC1 59 receptor tyrosine kinase inhibitor 59 MicuRx 59 selectively inhibit 59 RAF kinase 59 endothelin antagonist 58 SPL# Gel vaginal microbicide 58 favorable pharmacokinetic profile 58 SAR# [002] 58 anti CD3 monoclonal 58 commercialize OncoGenex lead 58 antitumour 58 acetylcholinesterase AChE 58 Captisol ® 58 peripherally acting 58 DP VPA 58 Pertuzumab 58 synergistic combinations 58 tumor vascular disrupting 58 Lisofylline LSF 58 melanocortin receptor agonists 58 anti TNFa 58 novel orally administered 58 Aflibercept 58 nilotinib Tasigna 58 antiangiogenesis 58 pharmacogenomic translational research 58 psoriasis rheumatoid arthritis 58 Zoraxel 58 biobetter 58 selective modulator 58 oxidative stress inducer 58 BNC# 58 potently inhibited 58 SNALP technology 58 Romidepsin 58 liposomal delivery 58 GLPG# 58 Initiates Enrollment 58 ALN PCS 58 PSMA ADC 58 oral PTH 58 anthrax monoclonal antibody 58 delta gamma agonist 58 PF # [002] 58 Bayer HealthCare Onyx Pharmaceuticals 58 including eniluracil ADH 58 PORxin TM platforms 58 JAK inhibitor 58 Genasense ® oblimersen 58 Deforolimus 58 Sphingomab 58 investigational hepatitis C 58 Enzastaurin 58 Anidulafungin 58 Rigel R# 58 FTIs 58 telomerase inhibitor 58 Prodarsan R 58 Talactoferrin 58 Syncria albiglutide 58 IgG1 monoclonal antibody 58 humanized antibody 58 investigational pan BCR 58 RAS MAPK pathway 58 novel topoisomerase 58 Endotis 58 Hsp# Inhibitor 58 reslizumab 58 pharmacological chaperone 58 #HT# 58 peptide conjugated 58 Anti Tumor 58 renin inhibitors 58 small molecule activator 58 Crofelemer budesonide foam 58 SinuNase ™ 58 highly selective inhibitor 58 anti mitotic 58 relapsed leukemia 58 nanopharmaceutical 58 ASG 5ME 58 5 HT2C 58 targeted radiotherapeutics 58 novel RNAi therapeutics 58 CYP#A# isoenzyme 58 Ligand proprietary 58 LPA1 58 Silodosin 58 Prodarsan ® 58 platforms GVAX 58 Epothilones 58 HCV protease inhibitors 58 targeting CD# 58 diagnostic biomarker 58 acetonide FA 58 ASONEP ™ 58 pralatrexate injection folate analogue 58 immunomodulatory 58 selective adenosine 58 MTP inhibitors 58 NP2 Enkephalin 58 Antiangiogenic 58 molecular chaperone regulation 58 reformulates existing FDA 58 polyketide 58 targeted antifolate 58 ATL/TV# 58 GeneICE 58 systemic RNAi 58 HepDirect prodrug 58 pregabalin Lyrica 58 allogeneic cell 58 Lisofylline 58 systemic antifungal 58 MAGE A3 ASCI 58 either acutely decompensated 58 M# rationally 58 anti CD3 antibody 58 Hedgehog agonist 58 thalidomide Thalomid 58 HCV NS5B polymerase 58 Maribavir 58 PDE4 modulators 58 TBC# 58 VEGFR2 inhibitor 58 S/GSK# 58 investigational integrase inhibitor 58 Inotek Pharmaceuticals Corporation 58 targeted covalent 58 Zemiva TM 58 VEGF inhibitors 58 BRAF inhibitor 58 Phase #b/#a clinical 58 HuLuc# 58 selective serotonin 2C receptor 58 CCR5 receptor antagonists 58 rifalazil 58 statin HMG CoA reductase 58 ovarian cancer chronic hepatitis 58 polysaccharide polymer 58 echinocandins 58 DGAT 58 includes AstraZeneca Accolate 58 novel peptides 58 sodium Injection 58 aflibercept VEGF Trap 58 NF kB Decoy 58 BZL# 58 EGEN 58 include VALSTAR TM 58 demethylating agents 58 Cathepsin S 58 MAXY G# 58 PEG SN# 58 ViroChem 58 MEK inhibitor 58 lipopeptide 58 naltrexone hydrochloride 58 rhIGF-I/rhIGFBP-3 58 neuro inflammatory disorders 58 5 HT2A inverse 58 immuno modulatory 58 IMiDs 58 PI3K/mTOR 58 novel antiviral therapeutics 58 CobaCyte 58 CINQUIL 58 anti fibrotic 58 Exherin TM 58 Neugene 58 Eniluracil 57 TNF alpha antagonist 57 histone deacetylase inhibitors 57 Histone deacetylase 57 blood clot dissolving 57 small molecule VR1 57 utilizes InSite Vision 57 recombinant PSMA vaccine 57 Dr. Aiping Young 57 cytotoxic T lymphocyte 57 peptidic 57 attach auristatin 57 selective inhibitors 57 Fovea Pharmaceuticals subsidiary 57 candidate custirsen 57 antibiofilm 57 targeting PCSK9 57 TOCOSOL Camptothecin 57 auristatin 57 imexon 57 antimetabolite 57 HIV integrase inhibitors 57 selective adhesion molecule 57 HCV NS3 protease 57 PNP inhibitor 57 antisense inhibitor 57 HCD# [002] 57 HCV RNA polymerase 57 anticancer compounds 57 infectious diseases autoimmune diseases 57 PARI Pharma focuses 57 Onconase 57 candidate CRLX# 57 selective orally bioavailable 57 mild vasodilator 57 buccal delivery 57 HMG CoA reductase inhibitors 57 GSK3B 57 Oral NKTR 57 clinically differentiated 57 AMPAKINE 57 lapatinib Tykerb 57 TLR agonists 57 optimized siRNA 57 regenerative stem cell 57 Hsp# inhibition 57 XL# XL# 57 anti resorptive 57 selective angiogenic kinase inhibitor 57 humanized monoclonal antibodies 57 EGFR HER 57 synthetic peptide containing 57 HIV integrase inhibitor 57 immunotherapeutic approaches 57 PTH analogue 57 NEUGENE R 57 beta 1a 57 selective inverse agonist 57 personalized cellular immunotherapy 57 Alexza Staccato 57 systemic RNAi therapeutic 57 poly ADP ribose polymerase 57 treats acute lymphoblastic 57 SinuNase TM 57 potent anti oxidant 57 midstage trials 57 inhibit replication 57 Gemzar gemcitabine 57 trastuzumab Herceptin R 57 factor TNF 57 evaluating picoplatin 57 SYN# 57 Aviptadil 57 Muraglitazar 57 XmAb ® 57 ficlatuzumab 57 antifolates 57 GPR# agonists 57 Pruvel ™ 57 cannabinor 57 antiproliferative effects 57 γ secretase 57 glucokinase activator 57 pertuzumab 57 serious systemic Staphylococcal 57 gamma secretase inhibitors 57 nonviral 57 predictive toxicology 57 neuroprotective properties 57 Cotara R 57 anti CD3 57 Preclinical studies suggest 57 neuropathic pain metabolic diseases 57 Proellex TM 57 penetrating peptides 57 certain protein tyrosine 57 validating biomarkers 57 tyrosine kinase inhibitor TKI 57 geldanamycin 57 prokinetic agent 57 CYT# novel 57 cognition enhancing 57 OvaRex R 57 p# MAP kinase inhibitor 57 therapeutic monoclonal antibodies 57 developing TB4 57 delipidation 57 nucleotide analogue 57 histone deacetylase HDAC inhibitor 57 non nucleoside polymerase 57 YONDELIS R 57 Alfacell proprietary ribonuclease 57 neuroactive 57 PEG irinotecan 57 drug GAP #B# 57 compound perifosine 57 HuMax TAC 57 Inc. AMEX YMI 57 CBLC# 57 Receptors GPCRs 57 CDDO Im 57 Immunotherapeutic 57 Blinatumomab 57 Nutra Pharma wholly owned 57 Cand5 57 generation Hsp# inhibitor 57 Cyclooxygenase Inhibiting Nitric Oxide 57 refractory chronic lymphocytic 57 systemically administered 57 recurrent metastatic ovarian cancer 57 orally bioavailable mimics 57 Aurora kinase inhibitors 57 immune stimulatory 57 P#X# antagonist 57 BHT DNA 57 torsemide ER 57 lintuzumab SGN 57 ospemifene 57 Vitaxin 57 antitumor 57 allosteric modulator 57 recombinant plasma 57 itraconazole Sporanox 57 clinically validated targets 57 International LAB Pharma 57 ELND-#/AZD-# 57 EndoTAG TM 57 Innovive Pharmaceuticals 57 SPC# [001] 57 MKC# MKC# PP 57 potent antibacterial 57 RGB # 57 4SC AG ISIN DE# 57 farletuzumab 57 peptibody 57 BioLineRx clinical 57 selective antagonist 57 folate analogue metabolic 57 stem cell mobilizer 57 Omacetaxine 57 ARIKACE ™ 57 sodium glucose transporter 57 Lu AA# 57 sulindac 57 ATL# [001] 57 FOLFOX chemotherapy 57 hypoxia selective 57 oral picoplatin 57 proven DuraSite ® 57 nalbuphine ER 57 GW# [003] 57 Enanta Pharmaceuticals 57 DepoVax 57 FOLOTYN ® 57 Atripla combines 57 cardiotoxic 57 nicotinic alpha 7 57 stable nucleic acid 57 maturation inhibition 57 targeted biologic therapies 57 platform HDL Mimetic 57 superparamagnetic iron oxide nanoparticles 57 using ImmunoGen TAP 57 BiTE R 57 HuMax EGFr 57 small molecule PEGylation 57 Pepducin 57 Hedgehog inhibitor 57 candidate REP# 57 ocular formulation 57 OHR/AVR# 57 muscarinic receptor agonist 57 trastuzumab DM1 T DM1 57 ImQuest 57 NS5b 57 ART# 57 immune modulator 57 Bevasiranib 57 Talabostat 57 Darinaparsin 57 liposome encapsulated 57 selective androgen receptor modulators 57 DNA methyltransferases 57 Hedgehog signaling pathway 57 endothelin receptor 57 SGLT Inhibitors 57 immune modulation 57 NNR Therapeutics 57 taxane derivative 57 ® bortezomib 57 insulin sensitizing 57 Vidaza ® 57 ophthalmology dermatology cardiovascular disease 57 HCV antiviral 57 preclinically 57 Tesmilifene 57 potent inhibitors 56 protein tyrosine phosphatase 1B 56 Menerba 56 theranostic 56 peptides proteins 56 dipeptidyl peptidase IV 56 peptide mimetics 56 GSK# [002] 56 HGS# 56 XmAb 56 Oxytrex TM 56 HEPLISAV TM hepatitis B 56 bortezomib Velcade R 56 selective inhibition 56 immune modulatory 56 Fleximer R 56 novel chimeric natriuretic 56 nilotinib Tasigna ® 56 MEK inhibitors 56 Dyax phage display 56 virus HCV protease inhibitor 56 neurology immunology 56 polymerase inhibitors 56 Surfaxin LS 56 Chemotherapeutic 56 DepoVax TM 56 EGS# 56 hereditary emphysema 56 PDGF receptor 56 Trofex TM 56 investigational monoclonal antibody 56 eligen R technology 56 ArQule Kinase Inhibitor Platform 56 lipid nanoparticle 56 proprietary intranasal insulin 56 ImmunoVEX HSV2 56 Long acting beta2 56 antiangiogenic activity 56 prostaglandin D2 56 Novartis NVS Snapshot Report 56 inhibit VEGF 56 inflammation metabolic disorders 56 Exherin 56 SGLT inhibitors 56 oral isotype selective HDAC 56 Novosom 56 beta HSD1 56 TRIOLEX ™ 56 selectively inhibit replication 56 LAS# [002] 56 InterfeRx TM 56 HCV polymerase inhibitors 56 anti PlGF 56 oral opioid modulator 56 POTELLIGENT ® Technology 56 ASONEP 56 Atiprimod 56 BiTE ® 56 sodium thiosulfate STS 56 Myocet 56 mGluR5 antagonists 56 vivo preclinical 56 small molecule defensin 56 novel emulsion formulation 56 ophthalmology oncology 56 Vincristine 56 Factor Receptor 56 DGAT1 inhibitors 56 Cobalamin 56 pharmacokinetic interactions 56 preclinical efficacy 56 siRNA therapeutics 56 BRAF kinase 56 JAK3 56 neratinib 56 oncolytic viruses 56 targets Galectin receptors 56 Pitavastatin 56 CYT# vascular disrupting 56 AQD class 56 Curaxins 56 glucagon receptor 56 cilengitide 56 Temsirolimus 56 PEGylated 56 seliciclib CYC# 56 small molecule agonists 56 radioprotective 56 discodermolide 56 catalytic antioxidant compounds 56 endosomal release 56 Apoptone HE# 56 Receptos 56 vosaroxin 56 volociximab 56 treating neuropathic pain 56 Ceflatonin R 56 Celator 56 detection reagents 56 Elotuzumab 56 oncolytic 56 erlotinib Tarceva 56 NS5B polymerase 56 inhibit viral replication 56 therapeutics diagnostics 56 BCR ABL inhibitors 56 vascular disrupting 56 Elacytarabine 56 PrevOnco ™ 56 semi synthetic lipoglycopeptide 56 selective A2A adenosine receptor 56 Janus Kinase 56 HCV protease 56 ZFNs clinical trials 56 melanocortin receptor 56 Phase IIb clinical trials 56 Topoisomerase II 56 ANG# 56 docetaxel Taxotere R 56 biologic therapeutics 56 Atrasentan 56 flavopiridol 56 peptidomimetic 56 insulin sensitizers 56 Budesonide foam crofelemer 56 HCV protease inhibitor 56 visilizumab 56 Anticalin 56 romidepsin novel 56 Cephalon Oncology 56 Enanta 56 alkylating 56 immunotherapeutic agent 56 Euronext Amsterdam GLPGA 56 rolapitant 56 SomatoKine 56 MGd 56 Spiegelmer ® 56 R Rituximab Herceptin 56 tezampanel NGX# 56 antiresorptive 56 huC# DM4 56 Vytorin combines 56 hepatitis C protease inhibitor 56 Tykerb lapatinib 56 MediGene focuses 56 triterpenoids 56 CYP#A# CYP#D# 56 macrocyclic lactone 56 Protease inhibitors 56 Sudhir Agrawal D.Phil 56 molecular biology genomics proteomics 56 generation antisense 56 Guanilib 56 fatty acid amide hydrolase 56 PU H# 56 tezampanel 56 agonistic human 56 GRNVAC1 56 lipid particle 56 Symadex 56 selectively inhibits 56 Belimumab 56 NS#/#A protease 56 oral ferric iron 56 vascular disrupting agent 56 Anti VEGF 56 generation URAT1 inhibitor 56 cladribine Cladribine Tablets 56 Zolinza 56 Viprovex TM 56 proprietary MSCRAMM protein 56 Aganocide TM 56 OncoVEX GM CSF 56 alpha#beta# 56 oral antiplatelet agent 56 SCIB1 56 proprietary LNA 56 cytostatic 56 TOCOSOL 56 nucleoside tide analogs 56 TRO# 56 TLR9 agonist 56 Integrase inhibitors 56 Aurora kinase inhibitor 56 aldehyde dehydrogenase ALDH2 deficiency 56 OncoVEX 56 M2 subunit 56 taxol 56 JAK#/JAK# 56 Angiotensin Converting Enzyme 56 HCV nucleoside polymerase inhibitors 56 microRNA antagonists 56 CDK inhibitor 56 engineered proteases 56 candidate KRN# 56 R Saizen R 56 parenterally administered 56 Aurora Kinase 56 Dapagliflozin 56 Intarcia 56 Enkephalin 56 carbohydrate polymer 56 small molecule thrombopoietin 56 High Impact AMPAKINE 56 Charlesson 56 Anticalins R 56 BRAF inhibitors 56 novel orally bioavailable 56 cyclin dependent kinase inhibitor 56 Hsp# chaperone system 56 immunoregulatory 56 Arcelis ™ 56 Cetrorelix 56 commercialize apixaban 56 deforolimus 56 GDIR 56 ALK inhibitors 56 immunologic diseases 56 iRGD 56 peptidic compound 56 oral nucleoside analogue 56 Kevetrin ™ 56 novel antimitotic agent 56 product platforms GVAX 56 BioSante LibiGel Phase III 56 novel immunotherapies 56 CYC# 56 Elvitegravir 56 TLK# 56 Smac mimetic 56 Vidaza azacitidine 56 DPX Survivac 56 Ii protein 56 cytoprotective 56 Quinamed R 56 Aplidin R 56 Daclizumab 56 DPOLT 56 Micromet BiTE 56 Cyclosert 56 antisense therapies 56 CoVal TM fusion